Quantcast

Latest Biosimilar Stories

2014-11-27 20:21:26

LONDON, Nov. 27, 2014 /PRNewswire/ -- INTRODUCTIONPrefilled syringes are gaining strong acceptance in the market as drug delivery systems for injectable drugs.

2014-11-21 04:21:49

DALLAS, November 21, 2014 /PRNewswire/ -- ReportsnReports.com adds Global Oncology Biosimilars Market 2014-2018 industry research report of 71 pages to the life science

2014-11-19 12:25:57

Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,

2014-11-17 23:01:58

FDA Can Use Existing Authority to Lower Drug Costs for Consumers, Employers and Public Programs Washington D.C.

2014-11-17 12:27:24

FDA Can Use Existing Authority to Lower Drug Costs for Consumers, Employers and Public Programs WASHINGTON, Nov.

2014-11-11 16:23:45

Surveyed German Nephrologists Report that the Majority of Their Patients Treated with Epoetin Alfa Receive a Biosimilar, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-11-04 12:28:43

Novel Therapies Demonstrating Evidence of Superior Head-to-Head Efficacy Will Expand the Role of Adjunct Therapy, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.

2014-10-29 16:28:36

Payers Employ a Variety of Cost-Control Measures to Manage the Utilization of Premium-Priced RA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.

2014-10-27 23:10:29

FDA has published a newlist of licensed biological products and interchangeable biosimilars, the “Purple Book”, which is being hyped as being the biological equivalent of the pharmaceutical


Word of the Day
dynamitard
  • A political dynamiter.
The word 'dynamitard' is related to 'dynamite', which comes from a Greek root meaning 'power' and was coined by Alfred Nobel.